'First bio-electronic medicine developed'

Image
Press Trust of India Washington
Last Updated : Oct 09 2018 | 1:45 PM IST

Scientists say they have developed the first bioelectronic medicine -- an implantable, biodegradable wireless device that speeds nerve regeneration and improves the healing of a damaged nerve.

Researchers at the Washington University in the US developed a device that delivers regular pulses of electricity to damaged peripheral nerves in rats after a surgical repair process, accelerating the regrowth of nerves in their legs and enhancing the ultimate recovery of muscle strength and control.

The size of a dime and the thickness of a sheet of paper, the wireless device operates for about two weeks before naturally absorbing into the body, according to the study published in the journal Nature Medicine.

The researchers envision that such transient engineered technologies one day could complement or replace pharmaceutical treatments for a variety of medical conditions in humans.

The technology, called "bioelectronic medicine," provides therapy and treatment over a clinically relevant period of time and directly at the site where it's needed, thereby reducing side effects or risks associated with conventional, permanent implants.

"These engineered systems provide active, therapeutic function in a programmable, dosed format and then naturally disappear into the body, without a trace," said John A Rogers from the Northwestern University in the US.

"This approach to therapy allows one to think about options that go beyond drugs and chemistry," Rogers said.

While the device has not been tested in humans, the findings offer promise as a future therapeutic option for nerve injury patients, researchers said.

For cases requiring surgery, standard practice is to administer some electrical stimulation during the surgery to aid recovery.

However, until now, doctors have lacked a means to continuously provide that added boost at various time points throughout the recovery and healing process.

"We know that electrical stimulation during surgery helps, but once the surgery is over, the window for intervening is closed," said Wilson Ray, an associate professor at Washington University.

"With this device, we have shown that electrical stimulation given on a scheduled basis can further enhance nerve recovery," Ray said.

Over the past eight years, Rogers and his lab developed a complete collection of electronic materials, device designs and manufacturing techniques for biodegradable devices with a broad range of options that offer the potential to address unmet medical needs.

The researchers designed and developed a thin, flexible device that wraps around an injured nerve and delivers electrical pulses at selected time points for days before the device harmlessly degrades in the body.

The device is powered and controlled wirelessly by a transmitter outside the body that acts much like a cellphone-charging mat.

Researchers then studied the bioelectronic device in rats with injured sciatic nerves which send signals up and down the legs and control the hamstrings and muscles of the lower legs and feet.

They used the device to provide one hour per day of electrical stimulation to the rats for one, three or six days or no electrical stimulation at all, and then monitored their recovery for the next 10 weeks.

The researchers found that any electrical stimulation was better than none at all at helping the rats recover muscle mass and muscle strength.

The more days of electrical stimulation the rats received, the more quickly and thoroughly they recovered nerve signalling and muscle strength. No adverse biological effects from the device and its reabsorption were found.

By varying the composition and thickness of the materials in the device, Rogers and colleagues can control the precise number of days it remains functional before being absorbed into the body. New versions can provide electrical pulses for weeks before degrading.

The ability of the device to degrade in the body takes the place of a second surgery to remove a non-biodegradable device, thereby eliminating additional risk to the patient.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 09 2018 | 1:45 PM IST

Next Story